IL29925A - Tetanus vaccine and process for preparing it - Google Patents
Tetanus vaccine and process for preparing itInfo
- Publication number
- IL29925A IL29925A IL29925A IL2992568A IL29925A IL 29925 A IL29925 A IL 29925A IL 29925 A IL29925 A IL 29925A IL 2992568 A IL2992568 A IL 2992568A IL 29925 A IL29925 A IL 29925A
- Authority
- IL
- Israel
- Prior art keywords
- tetanus
- vaccine
- urea
- toxoid
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1967B0092391 DE1617344B2 (de) | 1967-05-06 | 1967-05-06 | Verfahren zur herstellung eines tetanus-impfstoffes |
Publications (2)
Publication Number | Publication Date |
---|---|
IL29925A0 IL29925A0 (en) | 1968-07-25 |
IL29925A true IL29925A (en) | 1972-05-30 |
Family
ID=6986370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL29925A IL29925A (en) | 1967-05-06 | 1968-05-03 | Tetanus vaccine and process for preparing it |
Country Status (16)
Country | Link |
---|---|
US (1) | US3542920A (es) |
AT (1) | AT277460B (es) |
BE (1) | BE714696A (es) |
CH (1) | CH513653A (es) |
DE (1) | DE1617344B2 (es) |
DK (1) | DK119939B (es) |
ES (1) | ES353533A1 (es) |
FI (1) | FI45765C (es) |
FR (1) | FR7913M (es) |
GB (1) | GB1229988A (es) |
IE (1) | IE32044B1 (es) |
IL (1) | IL29925A (es) |
LU (1) | LU56019A1 (es) |
NL (1) | NL157803B (es) |
NO (1) | NO125455B (es) |
SE (1) | SE341984B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2340911A1 (de) * | 1973-08-13 | 1975-05-07 | Behringwerke Ag | Tetanus-antigen und verfahren zu seiner herstellung |
DE2355094C3 (de) * | 1973-11-03 | 1979-05-23 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines Tetanus-Impfstoffs |
DE2510987C2 (de) * | 1974-10-29 | 1983-03-24 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines Tetanusimpfstoffes |
DE2457047C3 (de) * | 1974-12-03 | 1979-10-31 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines Derivates der leichten Kette des Tetanustoxins, dessen Verwendung zur Tetanusprophylaxe |
EP0593176A3 (en) * | 1992-09-28 | 1995-03-01 | Wisconsin Alumni Res Found | Pharmaceutical compositions containing botulinum toxin and method of manufacture. |
-
1967
- 1967-05-06 DE DE1967B0092391 patent/DE1617344B2/de active Granted
-
1968
- 1968-04-30 FI FI681232A patent/FI45765C/fi active
- 1968-04-30 US US725525A patent/US3542920A/en not_active Expired - Lifetime
- 1968-04-30 IE IE505/68A patent/IE32044B1/xx unknown
- 1968-05-01 NL NL6806143.A patent/NL157803B/xx not_active IP Right Cessation
- 1968-05-03 IL IL29925A patent/IL29925A/en unknown
- 1968-05-03 NO NO1734/68A patent/NO125455B/no unknown
- 1968-05-03 AT AT428068A patent/AT277460B/de not_active IP Right Cessation
- 1968-05-03 LU LU56019D patent/LU56019A1/xx unknown
- 1968-05-03 CH CH656568A patent/CH513653A/de not_active IP Right Cessation
- 1968-05-03 DK DK206668AA patent/DK119939B/da unknown
- 1968-05-06 BE BE714696D patent/BE714696A/xx unknown
- 1968-05-06 SE SE6050/68A patent/SE341984B/xx unknown
- 1968-05-06 GB GB1229988D patent/GB1229988A/en not_active Expired
- 1968-08-05 FR FR161922A patent/FR7913M/fr not_active Expired
-
1969
- 1969-05-04 ES ES353533A patent/ES353533A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CH513653A (de) | 1971-10-15 |
SE341984B (es) | 1972-01-24 |
FI45765B (es) | 1972-05-31 |
NO125455B (es) | 1972-09-11 |
GB1229988A (es) | 1971-04-28 |
DE1617344A1 (de) | 1971-03-25 |
DE1617344B2 (de) | 1976-04-08 |
IE32044L (en) | 1968-11-06 |
LU56019A1 (es) | 1970-01-13 |
FI45765C (fi) | 1972-09-11 |
BE714696A (es) | 1968-11-06 |
US3542920A (en) | 1970-11-24 |
ES353533A1 (es) | 1970-01-16 |
DK119939B (da) | 1971-03-15 |
AT277460B (de) | 1969-12-29 |
NL6806143A (es) | 1968-11-07 |
IL29925A0 (en) | 1968-07-25 |
NL157803B (nl) | 1978-09-15 |
FR7913M (es) | 1970-05-11 |
IE32044B1 (en) | 1973-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schneerson et al. | Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. | |
Jansen | The toxic antigenic factors produced by Clostridium botulinum types C and D | |
EP0008969B1 (en) | Vaccine and method of making | |
US4324887A (en) | Type II group B Streptococci polysaccharide | |
DE69922990T2 (de) | Herstellungsverfahren von festphasekonjugateimpfstoffen | |
Watson et al. | Studies on Infection with Bacillus anthracis: III. Chemical and Immunological Properties of the Protective Antigen in Crude Extracts of Skin Lesions of B. anthraci | |
CA1123734A (en) | E. coli enterotoxin vaccine for veterinary and human use | |
US4402939A (en) | Vaccinating glycopeptidic antigenic fraction with a very high level of immunogenicity, isolated from cultures of pathogenic germs, processes for isolating said fraction and vaccines containing said fraction | |
US3674863A (en) | Polyvalent immunizing agents and methods for their production | |
IL29925A (en) | Tetanus vaccine and process for preparing it | |
Quinn et al. | Antigenicity of hyaluronic acid. | |
Smith et al. | A comparison of the amounts and the antigenicity of polymeric materials formed in aqueous solution by some β-lactam antibiotics | |
US4367222A (en) | Immune globulin specific to Group B streptococci | |
IE42760B1 (en) | Derivatives of the tetanus toxin, process for their preparation and agents containing them | |
US4356263A (en) | Method of making a polysaccharide vaccine | |
US4367223A (en) | Vaccine against Group B streptococci | |
US4367221A (en) | Immunization against Group B streptococci | |
Luecke et al. | Enhancement by endotoxin of the primary antibody response to bovine serum albumin in chickens | |
Lee et al. | Pneumococcal neuraminidase | |
Whang et al. | Differential effects on immunogenicity and antigenicity of heat, freezing and alkali treatment of bacterial antigens | |
Enders et al. | An immunological study of the A substance or acetyl polysaccharide of pneumococcus type I | |
Pillemer et al. | Immunochemistry of Toxins and Toxoids: IV. The Preparation of Purified Diphtherial Toxoid for Clinical Use | |
Johnson et al. | The immunological properties of alkali-treated proteins | |
Heidelberger et al. | Absence of a prosthetic group in a type-specific polysaccharide of pneumococcus | |
Seal et al. | Studies on the purification of alum-precipitated diphtheria toxoid |